Nadav Kidron, President and CEO at ORAMED PHARMACEUTICALS INC. (ORMP), bought 26,000 shares at $2.04 ($53K) on 2023-03-16, disclosed to the SEC on 2023-03-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ORMP | BUY | 2018-07-12 | $722 | — | Filing → |
| ORMP | SELL | 2018-07-12 | $365 | — | Filing → |
| ORMP | BUY | 2016-05-12 | $7K | — | Filing → |